Eckhard Kaukel

6.9k citations
51 papers · 5.3k · 3 hit papers · h-index 20

Impact in

    • Occupational and environmental lung diseases
    • Lung Cancer Treatments and Mutations
    • Pleural and Pulmonary Diseases
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
    • Lung Cancer Diagnosis and Treatment
    • Medical Imaging and Pathology Studies
  • Oncology top 2%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies

Papers in

    • Occupational and environmental lung diseases 9
    • Lung Cancer Treatments and Mutations 6
    • Pleural and Pulmonary Diseases 5
    • Lung Cancer Research Studies 10
    • Peptidase Inhibition and Analysis 4

Eckhard Kaukel

41 papers receiving 5.0k citations

Eckhard Kaukel's Hit Papers

Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial 2007 · 751 citations
7510+7+15Years since publication50010001.5k2.0k2.5k

Peers

Eckhard Kaukel
Comparison fields: 5 of 119
  • Pulmonary and Respiratory Medicine 3.4k
  • Oncology 1.5k
  • Biotechnology 177
  • Cancer Research 206
  • Biological Psychiatry 27
Replace Arta Monir Monjazeb with:
Arta Monir Monjazeb United States
Dörthe Schaue United States
Benjamin R. Tan United States
Gurkamal S. Chatta United States
Hei‐Cheul Jeung South Korea
Tadaaki Yamada Japan
Shoji Natsugoe Japan
Jane Yanagawa United States
Petra Rümmele Germany
Hisao Imai Japan
Eckhard Kaukel relative to Arta Monir Monjazeb United States Arta Monir Monjazeb's profile →
Citations per field
00.5×2×3.3×
Arta Monir Monjazeb · 1×
Citations per year

Countries citing papers authored by Eckhard Kaukel

Since Specialization
Citations

This map shows the geographic impact of Eckhard Kaukel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eckhard Kaukel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eckhard Kaukel more than expected).

Fields of papers citing papers by Eckhard Kaukel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eckhard Kaukel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eckhard Kaukel. The network helps show where Eckhard Kaukel may publish in the future.

Co-authors

The 25 scholars most cited alongside Eckhard Kaukel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eckhard Kaukel Line = papers co-authored together Eckhard Kaukel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
Hit paper breakdown →
20032533
2
Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group
Hit paper breakdown →
2003810
3
Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial
Hit paper breakdown →
2007751
4 2008143
5 1972131
6 2004121
7 200689
8 200383
9 197271
10 200370
11 200251
12 200650
13 197248
14 197342
15 200738
16 199031
17 200027
18 202326
19 200324
20
[Chemotherapy of advanced non-small-cell and small-cell bronchial carcinoma with bendamustine--a phase II study].
199821

About Eckhard Kaukel

Eckhard Kaukel is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Endocrine and Autonomic Systems, Epidemiology and Physiology, having authored 51 papers that have together received 5.3k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (10 papers), Occupational and environmental lung diseases (9 papers), Lung Cancer Treatments and Mutations (6 papers), Pleural and Pulmonary Diseases (5 papers), Neuroscience of respiration and sleep (5 papers), Cancer therapeutics and mechanisms (4 papers), Peptidase Inhibition and Analysis (4 papers) and Neuroendocrine Tumor Research Advances (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.4k citations), Oncology (1.5k citations), Biotechnology (177 citations), Cancer Research (206 citations) and Biological Psychiatry (27 citations). Eckhard Kaukel has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Ulrich Gatzemeier, Christian Manegold, James Thomas Symanowski, James J. Rusthoven, Claude A. Denham, Pierre Ruffiè, Michael Joseph Boyer, Paolo Paoletti, Salih Emri and Nicholas J. Vogelzang. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, Lung, Biochemical and Biophysical Research Communications and Respiration.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact